Clinical Trial Update: Exploratory Study of Breast Cancer With ABY025 [Phase 1, Phase 2]

View source ↗

Summary

The exploratory breast cancer study of ABY025 (Phase 1/2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ABY025

Snippet

Sponsor: Biomedical Radiation Sciences | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED